“Good News Doesn’t Spread, but Bad News Spreads Immediately”: Exploring DMPA Uptake, User Experiences, and Community Influences in an Urban Resettlement Colony of Delhi, A Mixed Method Study
This mixed-method study of an urban resettlement colony in Delhi reveals that while Depot medroxyprogesterone acetate (DMPA) offers practical advantages like privacy and long-acting protection, its low uptake and high discontinuation rates are primarily driven by inadequate pre-initiation counseling, unmanaged menstrual side effects amplified through peer networks, and male-dominated decision-making, necessitating structured counseling and couple-inclusive engagement to improve utilization.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the crowded, shifting neighborhoods of Delhi's urban resettlement colonies, families navigate a complex landscape of health choices. Among these choices is a specific form of birth control known as depot medroxyprogesterone acetate, or DMPA. Marketed in India as Antara, this method is a hormone injection given once every three months. It is free, highly effective at preventing pregnancy, and offers a significant advantage for many women: it does not require daily attention or a partner's involvement to work. Unlike daily pills that must be taken every morning, or devices that must be inserted by a doctor, this injection is a single, quarterly event. For women who struggle with daily routines or who value privacy, it seems like an ideal solution. Yet, despite being available at no cost in government clinics, very few women in these communities are actually using it. The question that drives this research is not whether the method works, but why a free, effective tool remains largely unused when so many women know it exists.
To answer this, a team of researchers from the All India Institute of Medical Sciences in New Delhi traveled to Dakshinpuri Extension, a resettlement colony in South-East Delhi. They wanted to understand the gap between knowing about the injection and actually using it. The study combined two approaches: they asked 306 married women of childbearing age about their knowledge and habits, and they held deep conversations with women, their husbands, mothers-in-law, and local health workers. The goal was to listen to the real stories behind the numbers, to see what happens when a woman decides to try the injection, and to understand why so many stop.
The researchers found a striking disconnect. More than half of the women in the study, about 54 percent, knew that the injection existed. However, only a tiny fraction, roughly 5 percent, were currently using it. This gap was not caused by a lack of availability; the clinics were open, and the medicine was free. Instead, the barrier lay in what happened after a woman received her first shot. Among the small group of women who had tried the injection, the most common reason for stopping was not a lack of support or money, but the way their bodies reacted. The leading reasons for quitting were headaches and changes in their menstrual bleeding. Many women experienced irregular periods, heavy bleeding, or a complete stop to their cycles. While these are known, expected side effects of the hormone, the women reported that no one had told them to expect them beforehand.
This lack of preparation turned manageable physical changes into frightening experiences. When a woman saw her period stop or bleed heavily, she often feared she was sick or pregnant. Because she had not been warned that this was a normal reaction to the injection, she stopped using it. The researchers discovered that this fear did not stay private. It traveled quickly through the community. One woman's alarming experience, shared with a friend or neighbor, became a powerful story that discouraged others from even trying. The researchers noted a pattern where bad news spreads immediately, while good news travels slowly. A single story of heavy bleeding could undo the work of months of health education, creating a cycle of fear that kept the method out of reach for many.
The study also revealed that the decision to use contraception is rarely made by a woman alone. In these households, the husband and the mother-in-law often hold the primary power to decide. Health workers frequently spoke only to the woman, leaving the men and the older female relatives uninformed. When a woman faced side effects, she often lacked the support of her family to manage them or to seek help. Furthermore, the researchers found that the health system itself had a gap. While local health workers, known as ASHAs, were good at bringing women to the clinic for the shot, they often failed to provide the detailed conversation needed before the injection. Women were told to come back in three months, but they were not told what to expect in the meantime or what to do if problems arose.
The participants in the study, including the women, their families, and the health workers themselves, offered a clear path forward. They agreed that the solution is not to push the injection harder, but to talk about it better. They called for structured counseling sessions where doctors and health workers explain the side effects clearly before the shot is given. They asked for husbands and mothers-in-law to be included in these conversations so that the whole family understands what is happening. They also pointed out a logistical issue: many women in these colonies are migrants who return to their home villages in other states. If the injection is not available in those other states, or if the supply chain is broken, women are forced to stop. The researchers concluded that fixing the supply chain and ensuring that counseling is thorough and honest are the keys to making this method work for the women who need it most.
Ultimately, the study shows that the problem is not the medicine itself, but the way it is introduced. The injection has real benefits: it is private, long-lasting, and free. But without a clear explanation of what to expect, and without the support of the family and the community, those benefits are lost. The researchers suggest that if health workers can take the time to prepare women for the changes in their bodies, and if they can bring the whole family into the conversation, the fear that currently blocks access can be replaced with informed choice. The goal is not just to get women to take the shot, but to ensure they feel safe and supported while using it, turning a method that is currently abandoned into one that is trusted and continued.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.